Dr. Gisela Mautner

Non-Executive Director

Dr. Gisela Mautner is a medical doctor with more than 20 years pharmaceutical industry experience encompassing all aspects of drug development, from clinical research through to product commercialisation. She is a seasoned senior leader, having held positions at MSD (Merck), Bayer and Amgen, where she successfully launched several new drugs in different therapeutic areas, including in cardiovascular diseases.

Dr. Mautner was appointed Chief Executive Officer and Managing Director of Noxopharm (ASX: NOX) in 2022, previously serving as its Chief Medical Officer since 2019. She holds a Doctor of Medicine and PhD from Germany, a Master of Public Health from Harvard University, and a Master of Business Administration from Northwestern University of Chicago.